Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:22 am Purchase |
2024-12-31 | 13G | Teva Pharmaceutical Industries Limited TEVA |
FMR CORP | 81,983,229 7.200% |
19,242,467 (+30.67%) |
Filing History |
| 2024-11-12 10:34 am Purchase |
2024-11-08 | 13G | Teva Pharmaceutical Industries Limited TEVA |
FMR CORP | 62,740,762 5.537% |
33,877,274 (+117.37%) |
Filing History |
| 2024-04-09 10:26 am Purchase |
2024-04-01 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Phoenix Financial Ltd. | 54,144,997 4.830% |
54,144,997 (New Position) |
Filing History |
| 2024-02-01 08:03 am Purchase |
2023-12-31 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Phoenix Financial Ltd. | 60,522,178 5.400% |
60,522,178 (New Position) |
Filing History |
| 2023-06-09 12:32 pm Sale |
2023-06-12 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 0 0.000% |
-114,793,989 (Position Closed) |
Filing History |
| 2023-02-13 3:32 pm Sale |
2023-02-14 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 114,793,989 10.300% |
-17,556,761 (-13.27%) |
Filing History |
| 2022-02-11 12:22 pm Purchase |
2022-02-14 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 132,350,750 12.000% |
2,210,503 (+1.70%) |
Filing History |
| 2021-02-16 3:58 pm Purchase |
2021-02-16 | 13G | Teva Pharmaceutical Industries Limited TEVA |
Capital Research Global Investors | 130,140,247 11.900% |
130,140,247 (New Position) |
Filing History |
| 2021-02-11 4:18 pm Purchase |
2020-12-31 | 13G | American Well Corporation AMWL |
TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA |
533,333 5.300% |
533,333 (New Position) |
Filing History |
| 2021-02-03 1:13 pm Sale |
2020-12-31 | 13G | Teva Pharmaceutical Industries Limited TEVA |
WELLINGTON MANAGEMENT CO LLP | 310,793 0.030% |
-80,813,203 (-99.62%) |
Filing History |